Dupilumab in Chinese Adult Participants With CRSwNP

NCT05878093 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Dupilumab
DRUG: Placebo
DRUG: Budesonide

Sponsor

Sanofi